Berneis K - Search Results

1

The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates.

Rizzo M, Berneis K. Rizzo M, et al. Among authors: berneis k. Curr Med Res Opin. 2007 May;23(5):1103-11. doi: 10.1185/030079907x187892. Curr Med Res Opin. 2007. PMID: 17519077 Review.

2

Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention?

Rizzo M, Berneis K. Rizzo M, et al. Among authors: berneis k. J Atheroscler Thromb. 2005;12(5):237-9. doi: 10.5551/jat.12.237. J Atheroscler Thromb. 2005. PMID: 16205019 Free article. Review.

3

Should we measure routinely the LDL peak particle size?

Rizzo M, Berneis K. Rizzo M, et al. Among authors: berneis k. Int J Cardiol. 2006 Feb 15;107(2):166-70. doi: 10.1016/j.ijcard.2005.02.035. Int J Cardiol. 2006. PMID: 16412793 Review.

4

Low-density lipoprotein size and cardiovascular prevention.

Rizzo M, Berneis K. Rizzo M, et al. Among authors: berneis k. Eur J Intern Med. 2006 Mar;17(2):77-80. doi: 10.1016/j.ejim.2005.08.013. Eur J Intern Med. 2006. PMID: 16490681

5

The clinical relevance of low-density-lipoproteins size modulation by statins.

Rizzo M, Berneis K. Rizzo M, et al. Among authors: berneis k. Cardiovasc Drugs Ther. 2006 Jun;20(3):205-17. doi: 10.1007/s10557-006-8283-x. Cardiovasc Drugs Ther. 2006. PMID: 16775666 Review.

6

Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome.

Berneis K, Rizzo M, Lazzarini V, Fruzzetti F, Carmina E. Berneis K, et al. J Clin Endocrinol Metab. 2007 Jan;92(1):186-9. doi: 10.1210/jc.2006-1705. Epub 2006 Oct 24. J Clin Endocrinol Metab. 2007. PMID: 17062762

7

Small, dense low-density-lipoproteins and the metabolic syndrome.

Rizzo M, Berneis K. Rizzo M, et al. Among authors: berneis k. Diabetes Metab Res Rev. 2007 Jan;23(1):14-20. doi: 10.1002/dmrr.694. Diabetes Metab Res Rev. 2007. PMID: 17080469 Review.

8

Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.

Rizzo M, Trepp R, Berneis K, Christ ER. Rizzo M, et al. Among authors: berneis k. Eur J Endocrinol. 2007 Mar;156(3):361-7. doi: 10.1530/EJE-06-0652. Eur J Endocrinol. 2007. PMID: 17322496 Clinical Trial.

9

Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease.

Rizzo M, Pernice V, Frasheri A, Berneis K. Rizzo M, et al. Among authors: berneis k. Atherosclerosis. 2008 Mar;197(1):237-41. doi: 10.1016/j.atherosclerosis.2007.03.034. Epub 2007 May 7. Atherosclerosis. 2008. PMID: 17485096

10

Effects of statins, fibrates, rosuvastatin, and ezetimibe beyond cholesterol: the modulation of LDL size and subclasses in high-risk patients.

Rizzo M, Rini GB, Berneis K. Rizzo M, et al. Among authors: berneis k. Adv Ther. 2007 May-Jun;24(3):575-82. doi: 10.1007/BF02848780. Adv Ther. 2007. PMID: 17660166 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters